Breakthrough Women in Science & Medicine series addresses breast cancer and dense breast tissue with Dr. Rachel Brem

Trending...
SCHAUMBURG, Ill., Oct. 1, 2024 ~ Dr. Rachel Brem, a renowned expert in breast imaging and intervention, will be featured in the upcoming episode of the Breakthrough Women in Science & Medicine series. The episode, which will be available to public television stations nationwide starting October 5th, will highlight Dr. Brem's groundbreaking work in promoting early breast cancer screening through education, access, and advocacy.

As a board-certified diagnostic radiologist and Professor of Radiology at the George Washington University School of Medicine & Health Sciences, Dr. Brem has dedicated her career to improving breast cancer detection and treatment. She is also the Vice Chair of Radiology and Director of Breast Imaging & Intervention at the university. In addition, she is the Medical Director and co-founder of The Brem Foundation to Defeat Breast Cancer.

Dr. Brem's passion for her work became even more personal when she was diagnosed with breast cancer at age 37. During a routine test of a new breast ultrasound machine, cancer was detected in her dense breast tissue. This experience only strengthened her commitment to educating others about the importance of early detection.

More on Marylandian
"I am delighted to be partnering with Breakthrough Women in Science and Medicine on this critically important project," shared Dr. Brem during filming for the episode. "Knowledge is power and this project empowers people with the information they need to optimize their screening protocol, diagnosis and treatment of breast cancer."

The upcoming episode will feature leading experts discussing important topics such as the recent FDA guidelines on reporting breast density and the U.S. Preventive Services Task Force's recommendations for breast cancer screening.

According to Dr. Matt Covington, a Breast Radiologist & Investigator at Huntsman Cancer Institute in Salt Lake City, Utah, understanding one's breast density is crucial for effective early detection strategies. "Increased breast density is a risk factor for breast cancer and influences a mammogram's effectiveness in identifying it at an early stage," he explained.

For women with dense breasts, it can be challenging to determine which secondary screening imaging is necessary. Dr. Laurie Margolies, Vice Chair for Breast Imaging at Icahn School of Medicine at Mount Sinai in New York City, emphasized the importance of understanding the value of secondary screening. "MRI, ultrasound, contrast-enhanced mammography, and molecular breast imaging are examples of technologies that supplement mammography to find cancers that are hidden by dense breast tissue," she said.

More on Marylandian
The episode was made possible through partnerships with four organizations: BC Ruckus, My Density Matters, Are You Dense, and FUJIFILM Healthcare Americas Corporation. These organizations share a common goal of promoting awareness and education about breast density and its impact on breast cancer detection.

BC Ruckus was founded to educate women about the limitations of mammography in detecting tumors in dense breast tissue and advocate for equitable access to supplemental screening options. My Density Matters aims to empower women to take control of their breast cancer screening by knowing their breast density. Are You Dense focuses on educating the public about the risks and challenges of dense breast tissue in detecting advanced stage breast cancer. And FUJIFILM Healthcare Americas Corporation is a leading innovator in diagnostic and enterprise imaging solutions designed to meet the evolving needs of healthcare.

The Breakthrough Women in Science & Medicine series is honored to feature Dr. Rachel Brem's groundbreaking work and hopes that this episode will empower individuals with the knowledge they need for early detection and treatment of breast cancer.
Filed Under: Business
Show All News | Report Violation

0 Comments

Latest on Marylandian